Claro Advisors LLC lowered its stake in BlackRock Capital Allocation Term Trust (NYSE:BCAT – Free Report) by 35.3% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 10,205 shares of the company’s stock after selling 5,560 shares during the period. Claro Advisors LLC’s holdings in BlackRock Capital Allocation Term Trust were worth $168,000 as of its most recent SEC filing.
A number of other large investors have also bought and sold shares of BCAT. Ashton Thomas Securities LLC purchased a new position in BlackRock Capital Allocation Term Trust during the 3rd quarter valued at about $156,000. Truist Financial Corp purchased a new position in shares of BlackRock Capital Allocation Term Trust during the second quarter valued at approximately $319,000. Kovack Advisors Inc. purchased a new position in shares of BlackRock Capital Allocation Term Trust during the third quarter valued at approximately $421,000. Almitas Capital LLC purchased a new stake in BlackRock Capital Allocation Term Trust in the second quarter worth $728,000. Finally, Fountainhead AM LLC boosted its holdings in BlackRock Capital Allocation Term Trust by 2.1% in the third quarter. Fountainhead AM LLC now owns 53,570 shares of the company’s stock valued at $881,000 after acquiring an additional 1,095 shares in the last quarter. 36.12% of the stock is owned by hedge funds and other institutional investors.
BlackRock Capital Allocation Term Trust Stock Performance
Shares of NYSE BCAT opened at $16.01 on Wednesday. The firm has a fifty day simple moving average of $16.27 and a two-hundred day simple moving average of $16.32. BlackRock Capital Allocation Term Trust has a 12 month low of $14.60 and a 12 month high of $17.18.
BlackRock Capital Allocation Term Trust Increases Dividend
Insider Buying and Selling at BlackRock Capital Allocation Term Trust
In other BlackRock Capital Allocation Term Trust news, major shareholder Saba Capital Management, L.P. sold 166,128 shares of the stock in a transaction on Monday, October 14th. The stock was sold at an average price of $16.60, for a total value of $2,757,724.80. Following the completion of the transaction, the insider now owns 15,096,159 shares in the company, valued at approximately $250,596,239.40. This represents a 1.09 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In the last three months, insiders have sold 723,927 shares of company stock valued at $11,925,047.
BlackRock Capital Allocation Term Trust Company Profile
–
Recommended Stories
- Five stocks we like better than BlackRock Capital Allocation Term Trust
- What is a Death Cross in Stocks?
- Super Micro Computer Soars 28%: Is It Really Out of the Woods?
- 3 Warren Buffett Stocks to Buy Now
- Traders Are Flocking Back to Oil: What’s Fueling the Optimism
- What Are Some of the Best Large-Cap Stocks to Buy?
- 3 Hot Stock Trends to Ride Into 2025
Want to see what other hedge funds are holding BCAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Capital Allocation Term Trust (NYSE:BCAT – Free Report).
Receive News & Ratings for BlackRock Capital Allocation Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Capital Allocation Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.